Advancing knowledge and identifying new therapies for lung disease.
The Simpson Querrey Lung Institute for Translational Science (SQLIFTS) at Northwestern University Feinberg School of Medicine uses a bedside-to-bench-to-bedside approach to seamlessly integrate patient care with research. Building on Northwestern Medicine’s nationally recognized track record of innovation and discovery in respiratory disease, SQLIFTS is ushering in a new era of research, education and care for patients with lung disease and its consequences.
Global Voices in Patient-Centered Research
Introducing Global Voices in Patient-Centered Research, a new conference series highlighting how research transforms lives. Our inaugural session kicked off on Friday, July 25 with a focus on cystic fibrosis. Speakers included cystic fibrosis clinicians Manu Jain, MD and Susanna McColley, MD at Northwestern, JP Clancy, MD, Senior Vice President of Clinical Research at the Cystic Fibrosis Foundation, and a patient living with cystic fibrosis.
This conference is sponsored by Northwestern University, the University of Pittsburgh, and the German Centers for Lung Research. Please check back again soon for updates on future events in this series
Our Work in Chicago & Beyond
Programs
SQLIFTS offers specialized expertise and resources specific to health education, translational innovation, discovery and technology.
Research
SQLIFTS brings together scientists and clinicians seeking to develop innovative therapies to treat patients with lung disease.
Nationally Ranked Healthcare Meets High-Impact Science
SQLIFTS works in conjunction with the Canning Thoracic Institute (CTI) at Northwestern Memorial Hospital, giving patients across Northwestern Medicine's 11 hospitals more opportunities to benefit from cutting-edge lung research.
Train in Lung Science at Northwestern
SQLIFTS is dedicated to training the next generation of scientists that will improve care for tomorrow's patients with lung disease. Programs span from high school to post-doctoral phases of training.